Nonalcoholic Fatty Liver Disease and Weight Loss / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
; (6): 597-602, 2018.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-690289
Responsible library:
WPRO
ABSTRACT
Nonalcoholic fatty liver disease(NAFLD)refers to hepatic steatosis without other known causes such as alcohol abuse or hepatic virus infection. NAFLD has become a chronic disease worldwide,and its prevalence is constantly growing. Hepatic insulin resistance caused by obesity results in the deposition of triglycerides in the liver,promoting the occurrence and development of NAFLD. Weight loss is the only safe and effective method for NAFLD. Lifestyle intervention plays a cornerstone role in treating NAFLD;however,most patients can not achieve and maintain the ideal body weight by lifestyle intervention alone. Glucagon-like peptide-1 receptor agonist and metabolic surgery are promising treatments for NAFLD.
Full text:
Available
Database:
WPRIM (Western Pacific)
Aspects:
Patient-preference
Language:
Chinese
Journal:
Acta Academiae Medicinae Sinicae
Year:
2018
Document type:
Article